These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20557288)

  • 1. Charged/Polar-residue scanning of the hydrophobic face of transmembrane domain 9 of the yeast glutathione transporter, hgt1p, reveals a conformationally critical region for substrate transport.
    Thakur A; Bachhawat AK
    G3 (Bethesda); 2015 Mar; 5(5):921-9. PubMed ID: 25784163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological Dissection of the Membrane Transport Protein Mhp1 Derived from Cysteine Accessibility and Mass Spectrometry.
    Calabrese AN; Jackson SM; Jones LN; Beckstein O; Heinkel F; Gsponer J; Sharples D; Sans M; Kokkinidou M; Pearson AR; Radford SE; Ashcroft AE; Henderson PJF
    Anal Chem; 2017 Sep; 89(17):8844-8852. PubMed ID: 28726379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Tumor-Targeted 6-Methyl Substituted Pemetrexed and Related Antifolates with Selective Loss of RFC Transport.
    Kaku K; Ravindra MP; Tong N; Choudhary S; Li X; Yu J; Karim M; Brzezinski M; O'Connor C; Hou Z; Matherly LH; Gangjee A
    ACS Med Chem Lett; 2023 Dec; 14(12):1682-1691. PubMed ID: 38116433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tales of tails in transporters.
    Mikros E; Diallinas G
    Open Biol; 2019 Jun; 9(6):190083. PubMed ID: 31213137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Concept of Folic Acid in Health and Disease.
    Shulpekova Y; Nechaev V; Kardasheva S; Sedova A; Kurbatova A; Bueverova E; Kopylov A; Malsagova K; Dlamini JC; Ivashkin V
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.
    Hou Z; Matherly LH
    Curr Top Membr; 2014; 73():175-204. PubMed ID: 24745983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of methotrexate transport is common in osteosarcoma tumor samples.
    Sowers R; Wenzel BD; Richardson C; Meyers PA; Healey JH; Levy AS; Gorlick R
    Sarcoma; 2011; 2011():834170. PubMed ID: 21234348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy.
    Matherly LH; Hou Z; Deng Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):111-28. PubMed ID: 17334909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From membrane to molecule to the third amino acid from the left with a membrane transport protein.
    Kaback HR; Wu J
    Q Rev Biophys; 1997 Nov; 30(4):333-64. PubMed ID: 9634651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate-specific binding and conformational changes involving Ser313 and transmembrane domain 8 of the human reduced folate carrier, as determined by site-directed mutagenesis and protein cross-linking.
    Hou Z; Wu J; Ye J; Cherian C; Matherly LH
    Biochem J; 2010 Sep; 430(2):265-74. PubMed ID: 20557288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.
    Hou Z; Stapels SE; Haska CL; Matherly LH
    J Biol Chem; 2005 Oct; 280(43):36206-13. PubMed ID: 16115875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of transport activity by co-expression of human reduced folate carrier half-molecules in transport-impaired K562 cells: localization of a substrate binding domain to transmembrane domains 7-12.
    Witt TL; Stapels SE; Matherly LH
    J Biol Chem; 2004 Nov; 279(45):46755-63. PubMed ID: 15337749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lysine 411 in substrate carboxyl group binding to the human reduced folate carrier, as determined by site-directed mutagenesis and affinity inhibition.
    Deng Y; Hou Z; Wang L; Cherian C; Wu J; Gangjee A; Matherly LH
    Mol Pharmacol; 2008 Apr; 73(4):1274-81. PubMed ID: 18182479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmembrane domains 4, 5, 7, 8, and 10 of the human reduced folate carrier are important structural or functional components of the transmembrane channel for folate substrates.
    Hou Z; Ye J; Haska CL; Matherly LH
    J Biol Chem; 2006 Nov; 281(44):33588-96. PubMed ID: 16923800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a cysteine-less human reduced folate carrier: localization of a substrate-binding domain by cysteine-scanning mutagenesis and cysteine accessibility methods.
    Cao W; Matherly LH
    Biochem J; 2003 Aug; 374(Pt 1):27-36. PubMed ID: 12749765
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.